May 12, 2009

Should You Own Shares of Pharmaceutical Product Development?

The Fool mentions in this article that Pharmaceutical Product Development is an official stock recommendation. The company is a few dollars above their 52 week low and more than 50% below their 52 week high.

The Fool explains more about their recent drop in this article. Given the long term prospects of the company, this may prove to be a good entry point.

No comments: